IL94270A0 - Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof - Google Patents

Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof

Info

Publication number
IL94270A0
IL94270A0 IL94270A IL9427090A IL94270A0 IL 94270 A0 IL94270 A0 IL 94270A0 IL 94270 A IL94270 A IL 94270A IL 9427090 A IL9427090 A IL 9427090A IL 94270 A0 IL94270 A0 IL 94270A0
Authority
IL
Israel
Prior art keywords
ergotypic
prevention
cells
treatment
methods
Prior art date
Application number
IL94270A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL94270A0 publication Critical patent/IL94270A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL94270A 1989-05-02 1990-05-02 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof IL94270A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34648689A 1989-05-02 1989-05-02

Publications (1)

Publication Number Publication Date
IL94270A0 true IL94270A0 (en) 1991-03-10

Family

ID=23359614

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94270A IL94270A0 (en) 1989-05-02 1990-05-02 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof

Country Status (5)

Country Link
EP (1) EP0427850A4 (xx)
JP (1) JPH04500689A (xx)
CA (1) CA2032138A1 (xx)
IL (1) IL94270A0 (xx)
WO (1) WO1990014068A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552300A (en) * 1994-01-13 1996-09-03 T Cell Sciences, Inc. T cell antigen receptor V region proteins and methods of preparation thereof

Also Published As

Publication number Publication date
EP0427850A4 (en) 1992-01-15
EP0427850A1 (en) 1991-05-22
CA2032138A1 (en) 1990-11-03
WO1990014068A3 (en) 1991-02-07
JPH04500689A (ja) 1992-02-06
WO1990014068A2 (en) 1990-11-29

Similar Documents

Publication Publication Date Title
SG49658A1 (en) Treatment of condition and disease
EP0205579A4 (en) METHODS AND COMPOSITIONS FOR USE IN THE DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES.
JPS6454092A (en) Solid scintillator and its treatment
EP0333344A3 (en) Corneal implants and manufacture and use thereof
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
EP0506893A4 (en) Diagnosis and treatment of diseases
OA09658A (en) Materials and methods for the treatment of foreign tissue
AU1279788A (en) Compounds and treatment
US5011841B1 (en) Treatment of depression
AU1118588A (en) Process and equipment for the rapid determination of the spermium cell count and/or living spermium count
AU4762893A (en) Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases.
IL94270A0 (en) Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
ZA909314B (en) Treatment of hsv
EP0436717A4 (en) Method of treatment with medical agents
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
EP0427942A3 (en) Process for the preparation of s-triazine-sulfenimides and their use
AU8094887A (en) Water treatment compositions and processes
EP0412938A3 (en) System for the treatment of contactlenses
AU7695891A (en) Treatment of autoimmune diseases
HRP931137A2 (en) Process for the preparation of human stephine b and the mutants thereof
AU7190087A (en) Water treatment polymers and methods of use thereof
GB8907372D0 (en) Cleansing of the human body
GB8903466D0 (en) Treatment of poisoning and compositions for use therein